| RS34515088 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS34515208 |
ROBO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental delay, ROBO1-related disorder |
| RS34515413 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
HEMOGLOBIN MALMO, Erythrocytosis |
| RS34515646 |
MLKL
|
Health Risk |
association |
Chronic multifocal osteomyelitis, Chronic multifocal osteomyelitis |
| RS34516117 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital long QT syndrome, Long QT syndrome |
| RS34517004 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS34517175 |
ERCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group D |
| RS34520362 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS34521483 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34523608 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Spherocytosis |
| RS34526199 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, Hypercholesterolemia |
| RS34526305 |
UGT1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperbilirubinemia, Lucey-Driscoll syndrome |
| RS34527846 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS34530014 |
TCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Transcobalamin I deficiency, TCN1-related disorder |
| RS34530803 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS34532796 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS34533941 |
HBB
|
Health Risk |
Likely pathogenic |
Beta zero thalassemia, Dominant beta-thalassemia |
| RS34542174 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS34542988 |
FOXRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS34547529 |
OTOG
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Autosomal recessive nonsyndromic hearing loss 18B |
| RS34548294 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34555120 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS34557412 |
TNFRSF13B
|
Health Risk |
Conflicting classifications of pathogenicity; risk factor |
Immunoglobulin A deficiency 2, Immunodeficiency |
| RS34559250 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS34560788 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, WRN-related disorder |
| RS34563000 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemoglobinopathy, beta Thalassemia |
| RS34563188 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS34565987 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS34566895 |
COG6
|
Health Risk |
Conflicting classifications of pathogenicity |
COG6-congenital disorder of glycosylation, Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome |
| RS34567401 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS34570933 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS34570972 |
NUBPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS34571629 |
PHYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Phytanic acid storage disease, PHYH-related disorder |
| RS34574788 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachydactyly type B1, Autosomal recessive Robinow syndrome |
| RS34575057 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS34578730 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alternating hemiplegia of childhood 2, Dystonia 12 |
| RS34580936 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS34583775 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
ATP8B1-related disorder, ATP8B1-related disorder |
| RS34583846 |
RAD51B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS34586048 |
PDGFRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile myofibromatosis, Basal ganglia calcification |
| RS34589386 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS34589476 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS34590975 |
LAMA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMA3-related disorder |
| RS34591340 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS34593399 |
MYOT
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 3, Myofibrillar myopathy 3 |
| RS34596189 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome, Usher syndrome type 2A |
| RS34596532 |
LIPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipidemia due to hepatic triglyceride lipase deficiency, Hyperlipidemia due to hepatic triglyceride lipase deficiency |
| RS34598192 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS34598529 |
HBB
|
Health Risk |
Pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS34599281 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS34602786 |
WDR11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34603892 |
COL4A2
|
Health Risk |
Pathogenic |
— |
| RS34604640 |
KCNE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 6, Cardiovascular phenotype |
| RS34607888 |
ERCC4
|
Health Risk |
Pathogenic |
— |
| RS34612342 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Endometrial carcinoma, Familial adenomatous polyposis 2 |
| RS34613633 |
GNPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 2, Colon adenocarcinoma |
| RS34614061 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS34615430 |
SLC25A15
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, Intellectual disability |
| RS34617074 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS34617196 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS34619378 |
RDH5
|
Health Risk |
Pathogenic |
— |
| RS34624018 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS34627040 |
RPE65
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS34629684 |
TNXB
|
Health Risk |
Likely pathogenic |
TNXB-related disorder, TNXB-related disorder |
| RS34632959 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS34635052 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant cerebellar ataxia, Autosomal dominant cerebellar ataxia |
| RS34635364 |
HBA1
|
Health Risk |
Pathogenic; other |
Heinz body anemia, HEMOGLOBIN TOYAMA |
| RS34637584 |
LRRK2
|
Health Risk |
Pathogenic/Likely pathogenic; risk factor |
Autosomal dominant Parkinson disease 8, Inborn genetic diseases |
| RS34640941 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS34647222 |
RARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 6, Pontoneocerebellar hypoplasia |
| RS34649270 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related disorder |
| RS34651888 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS34652786 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS34654141 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS34656239 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS34661166 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, Bartter disease type 1 |
| RS34661294 |
WDR36
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary open angle glaucoma, Primary open angle glaucoma |
| RS34663314 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34666647 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Hereditary cancer-predisposing syndrome |
| RS34667348 |
PHKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXb, Gastric cancer |
| RS34673364 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS34675173 |
AFG2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Hearing loss, autosomal recessive 119 |
| RS34676630 |
EYS
|
Health Risk |
Pathogenic |
Autosomal recessive retinitis pigmentosa, Retinitis pigmentosa 25 |
| RS34677017 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS34677591 |
SDHD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 3, Pheochromocytoma/paraganglioma syndrome 1 |
| RS34677717 |
PINK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive early-onset Parkinson disease 6, PINK1-related disorder |
| RS34678453 |
DICER1
|
Health Risk |
Pathogenic |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS34678567 |
POC5
|
Health Risk |
Conflicting classifications of pathogenicity |
POC5-related disorder, Retinal dystrophy |
| RS34682185 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma, Hirschsprung disease |
| RS34682727 |
SPATA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Leber congenital amaurosis 3 |
| RS34687433 |
ACTL9
|
Health Risk |
Pathogenic |
Spermatogenic failure 53, Spermatogenic failure 53 |
| RS34690599 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS34693334 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS34695403 |
IVD
|
Health Risk |
Conflicting classifications of pathogenicity |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS34700927 |
BUB1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Mosaic variegated aneuploidy syndrome 1, BUB1B-related disorder |
| RS34702903 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Autoinflammatory syndrome |
| RS34704118 |
MPDZ
|
Health Risk |
Conflicting classifications of pathogenicity |
MPDZ-related disorder, MPDZ-related disorder |
| RS34704828 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, Hemoglobinopathy |
| RS34705415 |
PDZD7
|
Health Risk |
Pathogenic |
PDZD7-related disorder, PDZD7-related disorder |
| RS34706299 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Tibial muscular dystrophy, Early-onset myopathy with fatal cardiomyopathy |